Insider Sale: EVP, Chief Legal Officer Van Der Vaart Sandra D Sells Shares of Laboratory Corp ...
Laboratory Corp of America(LH.US) Officer Sells US$421.66K in Common Stock
$Laboratory Corp of America(LH.US)$ Officer van der Vaart Sandra D sold 2,000 shares of common stock on May 14, 2024 at an average price of $210.8276 for a total value of $421.66K.Source: Announcement
Laboratory Corp Of America Holdings Insider Sold Shares Worth $421,655, According to a Recent SEC Filing
Sandra D Van Der Vaart, EVP, Chief Legal Officer, on May 14, 2024, sold 2,000 shares in Laboratory Corp Of America Holdings (LH) for $421,655. Following the Form 4 filing with the SEC, Sandra D Van De
Baird Adjusts Price Target on Laboratory Corp of America Holdings to $256 From $255, Keeps Outperform Rating
Laboratory Corp of America Holdings (LH) has an average outperform rating and a price target range of $210 to $262, according to analysts polled by Capital IQ. Price: 210.83, Change: -2.38, Percent Ch
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk During Pregnancy
Labcorp is now the only lab that can detect preeclampsia risk across all pregnancy trimesters BURLINGTON, N.C., May 15, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comp
Form 144 | Laboratory Corp of America(LH.US) Officer Proposes to Sell 421.66K in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Laboratory Corp of America(LH.US)$ Officer van der Vaart Sandra D intends to sell 2,000 shares of its common stock on May 14, with a total market value of approximatel
We Think Shareholders May Want To Consider A Review Of Laboratory Corporation of America Holdings' (NYSE:LH) CEO Compensation Package
Labcorp to Webcast Its Annual Meeting of Shareholders
BURLINGTON, N.C., May 8, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be
Laboratory: Invitae Acquisition Advances Labcorp's Specialty Testing Strategy in Key Areas Such as Oncology and Rare Diseases >LH
Laboratory: Invitae Acquisition Advances Labcorp's Specialty Testing Strategy in Key Areas Such as Oncology and Rare Diseases >LH
Invitae Receives Court Approval for Sale to Labcorp
Invitae Receives Court Approval for Sale to Labcorp
LabCorp Partner Geneoscopy Wins FDA Approval of Colorectal Cancer Test ColoSense
FDA Approves ColoSense – Geneoscopy's Noninvasive Multi-target Stool RNA (Mt-sRNA) Colorectal Cancer Screening Test
In average-risk individuals, ColoSense demonstrated 93% sensitivity for detecting colorectal cancer (CRC) and 45% sensitivity for detecting advanced adenomas (AA). The CRC-PREVENT study evaluated more than 1,800
Market Participants Recognise Laboratory Corporation of America Holdings' (NYSE:LH) Earnings
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may consider Laboratory Corporation of America Holdings (NYSE:LH) as a stock to avoid en
Form 144 | Laboratory Corp of America(LH.US) Director Proposes to Sell 100.18K in Common Stocks
SEC FILLINGS DISCLOSED/ May 3, $Laboratory Corp of America(LH.US)$ Director KERRII B ANDERSON intends to sell 500 shares of its common stock on May 3, with a total market value of approximately $100.1
Laboratory Corp of America(LH.US) Director Sells US$101.06K in Common Stock
$Laboratory Corp of America(LH.US)$ Director ANDERSON KERRII B sold 500 shares of common stock on Apr 30, May 2, 2024 at an average price of $202.1166 for a total value of $101.06K.Source: Announcemen
Insider Sale at Laboratory Corp of America Holdings (LH)
Laboratory Corp of America(LH.US) Officer Sells US$498.36K in Common Stock
$Laboratory Corp of America(LH.US)$ Officer Wilkinson Peter J sold 2,439 shares of common stock on Apr 29, 2024 at an average price of $204.329 for a total value of $498.36K.Source: Announcement What
Decoding Laboratory Corp of America Holdings (LH): A Strategic SWOT Insight
Baird Adjusts Laboratory Corp of America Holdings' Price Target to $255 From $244
Laboratory Corp of America Holdings (LH) has an average rating of outperform and price targets ranging from $210 to $262, according to analysts polled by Capital IQ.
Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
No Data